Drug Profile


Alternative Names: D-Trp-LHRH-PEA; LHRH agonist analogue; Somagard

Latest Information Update: 03 Aug 2006

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Nonindustrial source
  • Developer Nonindustrial source; Shire Pharmaceuticals Group
  • Class Antineoplastics; Hormones
  • Mechanism of Action Gonadotropin releasing hormone stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Endometriosis; Polycystic ovary syndrome; Precocious puberty; Prostate cancer; Uterine leiomyoma

Most Recent Events

  • 10 Mar 2003 A study has been added to the Endocrine disorders therapeutic trials section
  • 15 Feb 2001 Discontinued-III for Prostate cancer in Europe (IV-injection)
  • 22 Jun 2000 Discontinued-Clinical for Polycystic ovary syndrome in USA (SC)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top